{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:20"], "contactPoint": {"@type": "vcard:Contact", "fn": "Tuberculosis Epidemiologic Studies Consortium", "hasEmail": "mailto:tbesc3@cdc.gov"}, "description": "This was a head-to-head comparison of three FDA-approved tests for TB infection (Tuberculin Skin Test, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB) in populations at high risk of latent TB infection and/or progression to TB disease.", "distribution": [{"@type": "dcat:Distribution", "downloadURL": "https://data.cdc.gov/download/5hpj-p74g/application/x-zip-compressed", "mediaType": "application/x-zip-compressed"}], "identifier": "https://data.cdc.gov/api/views/5hpj-p74g", "issued": "2024-03-20", "keyword": ["interferon gamma release assay (igra)", "quantiferon (qft)", "t-spot.tb (tspot)", "tuberculin skin test (tst)", "tuberculosis"], "landingPage": "https://data.cdc.gov/d/5hpj-p74g", "license": "https://www.usa.gov/government-works", "modified": "2025-03-12", "programCode": ["009:027"], "publisher": {"@type": "org:Organization", "name": "Centers for Disease Control and Prevention"}, "theme": ["National Center for HIV", "STD", "Viral Hepatitis", "and TB Prevention"], "title": "Tuberculosis Epidemiologic Studies Consortium (TBESC)-II Part A: Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection with Mycobacterium tuberculosis and Prediction of Progression to Tuberculosis Disease"}